Journal of Substance Abuse Treatment
Volume 39, Issue 3 , Pages 236-247 , October 2010

Motivations for non-medical prescription drug use: A mixed methods analysis

  • Khary K. Rigg, M.S.

      Affiliations

    • Corresponding Author InformationCorresponding author. University of Delaware Center for Drug & Alcohol Studies 2121 Ponce de Leon Blvd., Suite #430 Coral Gables, FL 33134, USA. Tel.: +1 305 529 1911; fax: +305 529 2501.
  • ,
  • Gladys E. Ibañez, Ph.D.

Received 26 January 2010 ,Revised 2 April 2010 ,Accepted 10 June 2010.

References 

  1. Ball SA, Carroll KM, Canning-Ball M, Rounsaville BJ. Reasons for dropout from drug abuse treatment: Symptoms, personality, and motivation. Addictive Behaviors. 2006;31:320–330
  2. Beckham N. Motivational interviewing with hazardous drinkers. Journal of the American Academy of Nurse Practitioners. 2007;19:103–110
  3. Berndt TJ. Developmental changes in conformity to peers and parents. Developmental Psychology. 1979;15:608–616
  4. Boyd CJ, McCabe SE, Cranford JA, Young A. Adolescents' motivations to abuse prescription medications. Pediatrics. 2006;118:2472–2480
  5. Brands B, Blake J, Sproule B, Gourlay D, Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence. 2004;73:199–207
  6. Brown BB, Clasen DR, Eicher SA. Perceptions of peer pressure, peer conformity dispositions, and self-reported behavior among adolescents. Developmental Psychology. 1986;22:521–530
  7. Charmaz K. Grounded theory: Objectivist and constructivist methods. In:  Denzin NK,  Lincoln YS editor. Handbook of qualitative research. 2nd ed.. Thousand Oaks, CA: Sage Publications; 2000;p. 509–535
  8. Charmaz K. Qualitative interviewing and grounded theory analysis. In:  Holstein JA,  Gubrium JF editor. Inside interviewing: New lenses, new concerns. Thousand Oaks: Sage Publications; 2003;p. 311–330
  9. Compton WM, Volkow ND. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006;83:S4–S7
  10. Cosden M, Basch JE, Campos E, Greenwell A, Barazani S, Walker S. Effects of motivation and problem severity on court-based drug treatment. Crime Delinquency. 2006;52:599–618
  11. Davis WR, Johnson BD. Prescription opioids use, misuse, and diversion among street drug users in New York City. Drug & Alcohol Dependence. 2008;92:267–276
  12. DeLeon G, Melnick G, Hawke J. The motivation–readiness factor in drug treatment: Implications for research and policy. Advance in Medical Sociology. 2000;7:103–129
  13. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. Journal of Psychopharmacology. 1998;12:54–67
  14. DiClemente CC. Motivation for change: Implications for substance abuse. Psychological Science. 1999;10:209–213
  15. Epstein JA, Botyin GJ, Griffin KW, Diaz T. Role of ethnicity and gender in polydrug use among a longitudinal sample of inner-city adolescents. Journal of Alcohol and Drug Education. 1999;45:1–12
  16. Ferster CB, Skinner BF, Cheney CD, Morse WH, Dews PB. Schedules of reinforcement. (BF Skinner Reprint Series). Acton, MA: Copley Publishing Group; 1997;
  17. Gardos G, Cole JO, Tarsy D. Withdrawal syndromes associated with antipsychotic drugs. American Journal of Psychiatry. 1978;135:1321–1324
  18. Glaser BG, Strauss AL. Discovery of grounded theory: Strategies for qualitative research. Hawthorne, NY: Walter de Guyter; 1967;
  19. Huang B, Dawson DA, Stinson FS, Hasin DS, Ruan WJ, Saha TD, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry. 2006;67:1062–1073
  20. Iguchi MY, Handelsman L, Bickel WK, Griffiths RR. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug and Alcohol Dependence. 1993;32:257–266
  21. Jewers WM, Rawal YB, Allen CM, Kalmar JR, Fox E, Chacon GE, et al. Palatal perforation associated with intranasal prescription narcotic abuse. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics. 2005;99:594–597
  22. Khantzian EJ, Mack JE, Schatzberg AF. Heroin use as an attempt to cope: Clinical observations. American Journal of Psychiatry. 1974;131:160–164
  23. Kurtz SP, Inciardi JA. Crystal meth, gay men, and circuit parties. Law Enforcement Executive Forum. 2003;3:97–114
  24. Longshore D, Teruya C. Treatment motivation in drug users: A theory based analysis. Drug and Alcohol Dependence. 2006;81:179–188
  25. Maslow AH. A theory of human motivation. Psychological Reviews. 1943;50:370–396
  26. McCabe SE, Boyd CJ, Cranford JA, Teter CJ. Motives for nonmedical use of prescription opioids among high school seniors in the United States. Archives of Pediatrics and Adolescent Medicine. 2009;163:739–744
  27. McCabe SE, Cranford JA, Boyd CJ, Teter CJ. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addictive Behaviors. 2007;32:562–575
  28. McCabe SE, Cranford JA, Morales M, Young A. Simultaneous and concurrent polydrug use of alcohol and prescription drugs: Prevalence, correlates, and consequences. Journal of Studies on Alcohol. 2006;6:529–537
  29. McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction. 2005;100:96–106
  30. McCabe SE, Teter CJ. Drug use related problems among nonmedical users of prescription stimulants: A Web-based survey of college students from a Midwestern university. Drug and Alcohol Dependence. 2007;91:69–76
  31. Miller WR, Rollnick S. Motivational interviewing. Preparing people to change addictive behavior. New York: The Guildford Press.; 1991;
  32. Peterson PL, Baer JS, Wells E, Ginzler JA, Garrett SB. Short-term effects of a brief motivational intervention to reduce alcohol and drug risk among homeless adolescents. Psychol. Addictive Behaviors. 2006;20:254–264
  33. Pomazal RJ, Brown JD. Understanding drug use motivation: A new look at a current problem. Journal of Health & Social Behavior. 1977;18:212–222
  34. Rollnick S, Miller W. What is motivational interviewing?. Behavioral and Cognitive Psychotherapy. 1995;23:325–334
  35. Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence. 2007;90:64–71
  36. Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: A systematic review and meta-analysis. British Journal of General Practice. 2005;55:305–312
  37. Sherman SS, Plitt S, Hassan SU, Cheng Y, Zafar ST. Drug use, street survival, and risk behaviors among street children in Lahore, Pakistan. Journal of Urban Health. 2005;82:113–124
  38. Sigmon SC. Characterizing the emerging population of prescription opioid abusers. American Journal on Addictions. 2006;15:208–212
  39. Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Substance Use and Misuse. 2004;39:1–23
  40. Simoni-Wastila L, Strickler G. Risk factors associated with problem use of prescription drugs. American Journal of Public Health. 2004;94:266–268
  41. Stacy AW, Newcomb MD, Benlter PM. Cognitive motivation and drug use: A 9 year longitudinal study. Journal of Abnormal Psychology. 1991;100:502–515
  42. Sturza ML, Campbell R. An exploratory study of rape survivors' prescription drug use as a means of coping with sexual assault. Psychology of Women Quarterly. 2005;29:353–363
  43. Substance Abuse and Mental Health Services Administration [SAMSHA], Office of Applied Studies . Results from the 2005 National Survey on Drug use and Health: National Findings: NSDUH Series H-32 DPNS, Rockville, MD. 2006;
  44. Substance Abuse and Mental Health Services Administration [SAMSHA], Office of Applied Studies . Results from the 2006 National Survey on Drug use and Health: National Findings: NSDUH Series H-32 DPNS, Rockville, MD. 2007;
  45. Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health. 2005;53:253–262
  46. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: Prevalence, motives, and routes of administration. Pharmacotherapy. 2006;26:1501–1510
  47. Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC, Youniss J, Reid N, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. American Journal of Emergency Medicine. 2004;22:335–404
  48. Yewell J, Haydon R, Archer S, Manaligod JM. Complications of intranasal prescription narcotic abuse. Annals of Otology, Rhinology & Laryngology. Supplement. 2002;111:174–177

PII: S0740-5472(10)00131-5

doi: 10.1016/j.jsat.2010.06.004

Journal of Substance Abuse Treatment
Volume 39, Issue 3 , Pages 236-247 , October 2010